Gene · 7337
NIH grants2,489
NIH grants whose papers are about the gene, through NIH's grant-paper links.
81 to 100 of 2,489
Download this page as JSON| Grant | Title | UBE3A papers | Newest fiscal year |
|---|---|---|---|
| R01ES014901 | Molecular and Cellular Basis of PCB Developmental Neurotoxicity | 2 | 2025 |
| R01GM121907 | Genomic basis of phenotypic variability of complex disorders | 2 | 2025 |
| R01HD008188 | Reproductive Hormones - Biological and Molecular Actions | 2 | 2025 |
| R01HL121253 | L-type channel trafficking and modulation in heart | 2 | 2025 |
| R01MH085802 | Early developmental mechanisms of Rett Syndrome | 2 | 2025 |
| R01MH124808 | Genomic and functional characterization of ASD and ID-associated MYT1L mutation | 2 | 2025 |
| R01NS062829 | Signaling Mechanisms Regulating Rho GTPase-Dependent Synaptic Plasticity Underlying Memory in Health and Disease | 2 | 2025 |
| R01NS067525 | Parthanatos, PAAN/MIF nuclease Activation in Ischemic Injury | 2 | 2025 |
| R01NS131615 | Small Molecule Therapeutic Discovery for Angelman Syndrome | 2 | 2025 |
| R25MH077823 | Research Education for Future Physician-Scientists in Child Psychiatry | 2 | 2025 |
| R35GM118080 | Structural studies of RNA processing and ubiquitin-like protein modification | 2 | 2025 |
| R35GM119465 | Unraveling mechanisms of genome regulation to understand and improvehuman health | 2 | 2025 |
| R35GM128855 | Spindle Assembly Checkpoint Silencing | 2 | 2025 |
| R35GM142486 | Exploiting bacterial effector proteins to study human ubiquitin signaling | 2 | 2025 |
| R35NS116843 | Continuous Neurogenesis in the Mammalian Hippocampus | 2 | 2025 |
| T32AG000096 | Training in the Neurobiology of Aging and Alzheimers Disease | 2 | 2025 |
| T32AI007392 | Interdisciplinary Research Training Program in AIDS | 2 | 2025 |
| T32AI007526 | Emerging and Tropical Infectious Diseases | 2 | 2025 |
| T32CA009110 | Training in Areas Fundamental to Cancer Research | 2 | 2025 |
| T32CA009560 | Carcinogenesis Training Program | 2 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7337/grants?page=5